The indirect costs of ankylosing spondylitis: a systematic review and meta-analysis

References

• Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007;369:1379-90
   PubMed Web of Science ®Google Scholar
• Mok CC, Kwok CL, Ho LY, et al. Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. Arthritis Rheum 2011;63(5):1182-9
   PubMed Web of Science ®Google Scholar
• Krol M, Brouwer W. How to Estimate Productivity Costs in Economic Evaluations. Pharmacoeconomics 2014;32:335-44
   PubMed Web of Science ®Google Scholar
• Boonen A, van der Heijde D, Severens JL, et al. Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis. Ann Rheum Dis 2006;65:201-8
   PubMedGoogle Scholar
• Fautrel B, Benhamou M, Breban M, et al. Cost effectiveness of two therapeutic regimens of infliximab in ankylosing spondylitis: economic evaluation within a randomised controlled trial. Ann Rheum Dis 2010;69:424-7
   PubMedGoogle Scholar
• Boonen A, Severens JL. Ankylosing spondylitis: what is the cost to society, and can it be reduced? Best Pract Res Clin Rheumatol 2002;16:691-705
   PubMed Web of Science ®Google Scholar
• Sailly JC, Lebrun T. Les conséquenceséconomiquesetsociales de la pelvispondyliterhumatismale. Rev Epidemiol Sante Publique 1982;30(3):305-24
   PubMedGoogle Scholar
• Torres TM, Ferraz MB, Ciconelli RM. Resource utilisation and cost of ankylosing spondylitis in Brazil. Clin Exp Rheumatol 2010;28:490-7
   PubMed Web of Science ®Google Scholar
• Kobelt G, Sobocki P, Maksymowych WP. Costs and Quality of Life of Patients with Ankylosing Spondylitis in Canada. J Rheumatol 2006;33(2):289-95
   PubMed Web of Science ®Google Scholar
• Kruntoradova K, Klimes J, Dolezal T, et al. Work productivity and productivity costs of patients with rheumatoid arthritis, ankylosing spondylitis and psoriasis in The Czech Republic. Value Health 2012;15:7; (A448). Abstract
   Google Scholar
• Kruntoradova K, Klimes J, Dolezal T, et al. Work productivity and productivity costs of patients with ankylosing spondylitis in The Czech Republic. Value Health 2011;14:7 ( A312). Abstract
   Google Scholar
• Petrikova A, Dolezal T, Skoupá J. The direct and indirect costs of the ankylosing spondylitis in The Czech Republic – Comparison between 2005 and 2008 studies. Value in Health 2009;12:7; (A378). Abstract
   Google Scholar
• Petrikova A, Dolezal T, Klimes J, et al. The economic burden of the ankylosing spondylitis in the Czech Republic: comparison between 2005 and 2008. Rheumatol Int 2013;33:1813-19
   PubMed Web of Science ®Google Scholar
• Boonen A, van den Heuvel R, van Tubergen A, et al. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis. Ann Rheum Dis 2005;64:396-402
   PubMed Web of Science ®Google Scholar
• Van Tubergen A, Boonen A, Landewe R, et al. Cost effectiveness of combined spa–exercise therapy in ankylosing spondylitis: a randomized controlled trial. Arthritis Rheum 2002;47(5):459-67
   PubMedGoogle Scholar
• Rafia R, Ara R, Packham J, et al. Healthcare costs and productivity losses directly attributable to ankylosing spondylitis. Clin Exp Rheumatol 2012;30:246-53
   PubMed Web of Science ®Google Scholar
• Neilson AR, Sieper J, Deeg M. Cost-effectiveness of etanercept in patients with severe ankylosing spondylitis in Germany. Rheumatology 2010;49:2122-34
   PubMed Web of Science ®Google Scholar
• Zhu TY, Tam LS, Lee VWY, et al. Costs and quality of life of patients with ankylosing spondylitis in Hong Kong. Rheumatology 2008;47:1422-5
   PubMed Web of Science ®Google Scholar
• Kvamme MK, Lie E, Kvien TK, Kristiansen IS. Two-year direct and indirect costs for patients with inflammatory rheumatic joint diseases: data from real-life follow-up of patients in the NOR-DMARD registry. Rheumatology 2012;51:16181627
   Web of Science ®Google Scholar
• Kobelt G, Sobocki P, Mulero J, et al. The cost-effectiveness of infliximab in the treatment of ankylosing spondylitis in Spain. Comparison of clinical trial and clinical practice data. Scand J Rheumatol 2008;37:62-71
   PubMed Web of Science ®Google Scholar
• Kobelt G, Sobocki P, Mulero J, et al. The burden of ankylosing spondylitis in Spain. Value Health 2008;11(3):408-15
   PubMedGoogle Scholar
• Kobelt G, Andlin-Sobocki P, Collantes-Estevez E, et al. Mulero-Mendoza J at al. The cost of ankylosing spontylitis in Spain. An observational study in 600 patients. Ann Rheum Dis 2006;65(Suppl II): 283. Abstract
   Google Scholar
• Lee TJ, Park BH, Kim JW, et al. Cost-of-Illness and Quality of Life in Patients with Ankylosing Spondylitis at a Tertiary Hospital in Korea. J Korean Med Sci 2014;29:190-7
   PubMedGoogle Scholar
• Strömbeck B, Englund M, Bremander A, et al. Cost of Illness from the Public Payers’ Perspective in Patients with Ankylosing Spondylitis in Rheumatological Care. J Rheumatol 2010;37:2348-55
   PubMed Web of Science ®Google Scholar
• Husain MJ, Brophy S, Phillips CJ, et al. Impact of ankylosing spondylitis on work and productivity. Rheumatology (United Kingdom) 2012;51(Suppl 3):170-1; Abstract
   Google Scholar
• Ward MM. Functional disability predicts total costs in patients with ankylosing spondylitis. Arthritis Rheum 2002;46(1):223-31
   Google Scholar
• Younes M, Jalled A, Aydi Z, et al. Socioeconomic impact of ankylosing spondylitis in Tunisia. Joint Bone Spine 2010;77:41-6
   PubMedGoogle Scholar
• Malhan S, Pay S, Ataman S, et al. The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey. Value Health 2011;14(7): A306. Abstract
   Google Scholar
• Malhan S, Pay S, Ataman S, et al. The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey. Clin Exp Rheumatol 2012;30:202-7
   PubMedGoogle Scholar
• Boonen A, van der Heijde D, Landewé R, et al. Costs of ankylosing spondylitis in three European countries: the patient’s perspective. Ann Rheum Dis 2003;62:741-7
   PubMed Web of Science ®Google Scholar
• Boonen A, van der Heijde D, Landewé R, et al. Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries. Ann Rheum Dis 2002;61:429-37
   PubMed Web of Science ®Google Scholar
• Akkoc N, Direskeneli H, Erdem H, et al. Indirect costs associated with ankylosing spondylitis in Turkey. Ann Rheum Dis 2013;A1029; Abtract
   Google Scholar
• Boonen A, Brinkhuizen T, Landewé R, et al. Impact of ankylosing spondylitis on sick leave, presenteeism and unpaid productivity, and estimation of the societal cost. Ann Rheum Dis 2010;69:1123-8
   PubMed Web of Science ®Google Scholar
• Huscher D, Merkesdal S, Thiele K, et al. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis 2006;65:1175-83
   PubMed Web of Science ®Google Scholar
• Boonen A, Mau W. The economic burden of disease: comparison between rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 2009;27(Suppl 55):S112-17
   PubMedGoogle Scholar
• Franke LC, Ament AJHA, van de Laar MAFJ, et al. Cost-of-illness of rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 2009;27(Suppl 55):S118-23
   Google Scholar
• Boonen A, van der Heijde D, Landewé R, et al. Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries. Ann Rheum Dis 2003;62:732-40
   PubMed Web of Science ®Google Scholar
• Palla I, Trieste L, Tani C, et al. A systematic literature review of the economic impact of ankylosing spondylitis. Clin Exp Rheumatol 2012;30(Suppl 73):S136-41
   PubMedGoogle Scholar
• Boonen A, van der Heijde D. Review of the costs of illness of ankylosing spondylitis and methodologic notes. Expert Rev. Pharmacoeconomics Outcomes Res 2005;5(2):163-81
   PubMedGoogle Scholar
• Kobelt G, Andlin-Sobocki P, Brophy S, et al. The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade®). Rheumatology 2004;43:1158-66
   PubMed Web of Science ®Google Scholar
• Inflation calculator. Available from: http://fxtop.com/en/inflation-calculator.php
   Google Scholar
• OECD.Stat. Available from: http://stats.oecd.org/
   Google Scholar